According to this latest study, the 2021 growth of Molecular Influenza Diagnostic will have significant change from previous year. By the most conservative estimates of global Molecular Influenza Diagnostic market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Molecular Influenza Diagnostic market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Influenza Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Nucleic Acid Sequence Based Amplification (NASBA) Tests
Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-based Assays (SAMBA)
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
POCT
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Influenza Diagnostic Market Size 2016-2026
2.1.2 Molecular Influenza Diagnostic Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Molecular Influenza Diagnostic Segment by Type
2.2.1 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
2.2.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
2.2.3 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
2.2.4 Simple Amplification-based Assays (SAMBA)
2.3 Molecular Influenza Diagnostic Market Size by Type
2.3.1 Global Molecular Influenza Diagnostic Market Size CAGR by Type
2.3.2 Global Molecular Influenza Diagnostic Market Size Market Share by Type (2016-2021)
2.4 Molecular Influenza Diagnostic Segment by Application
2.4.1 Hospitals
2.4.2 POCT
2.4.3 Others
2.5 Molecular Influenza Diagnostic Market Size by Application
2.5.1 Global Molecular Influenza Diagnostic Market Size CAGR by Application
2.5.2 Global Molecular Influenza Diagnostic Market Size Market Share by Application (2016-2021)
3 Molecular Influenza Diagnostic Market Size by Players
3.1 Molecular Influenza Diagnostic Market Size Market Share by Players
3.1.1 Global Molecular Influenza Diagnostic Revenue by Players (2019-2021E)
3.1.2 Global Molecular Influenza Diagnostic Revenue Market Share by Players (2019-2021E)
3.2 Global Molecular Influenza Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Molecular Influenza Diagnostic by Regions
4.1 Molecular Influenza Diagnostic Market Size by Regions (2016-2021)
4.2 Americas Molecular Influenza Diagnostic Market Size Growth (2016-2021)
4.3 APAC Molecular Influenza Diagnostic Market Size Growth (2016-2021)
4.4 Europe Molecular Influenza Diagnostic Market Size Growth (2016-2021)
4.5 Middle East & Africa Molecular Influenza Diagnostic Market Size Growth (2016-2021)
5 Americas
5.1 Americas Molecular Influenza Diagnostic Market Size by Country (2016-2021)
5.2 Americas Molecular Influenza Diagnostic Market Size by Type (2016-2021)
5.3 Americas Molecular Influenza Diagnostic Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Influenza Diagnostic Market Size by Region (2016-2021)
6.2 APAC Molecular Influenza Diagnostic Market Size by Type (2016-2021)
6.3 APAC Molecular Influenza Diagnostic Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Molecular Influenza Diagnostic by Country (2016-2021)
7.2 Europe Molecular Influenza Diagnostic Market Size by Type (2016-2021)
7.3 Europe Molecular Influenza Diagnostic Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Influenza Diagnostic by Region (2016-2021)
8.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2021)
8.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Molecular Influenza Diagnostic Market Forecast
10.1 Global Molecular Influenza Diagnostic Forecast by Regions (2021-2026)
10.1.1 Global Molecular Influenza Diagnostic Forecast by Regions (2021-2026)
10.1.2 Americas Molecular Influenza Diagnostic Forecast
10.1.3 APAC Molecular Influenza Diagnostic Forecast
10.1.4 Europe Molecular Influenza Diagnostic Forecast
10.1.5 Middle East & Africa Molecular Influenza Diagnostic Forecast
10.2 Americas Molecular Influenza Diagnostic Forecast by Countries (2021-2026)
10.2.1 United States Molecular Influenza Diagnostic Market Forecast
10.2.2 Canada Molecular Influenza Diagnostic Market Forecast
10.2.3 Mexico Molecular Influenza Diagnostic Market Forecast
10.2.4 Brazil Molecular Influenza Diagnostic Market Forecast
10.3 APAC Molecular Influenza Diagnostic Forecast by Region (2021-2026)
10.3.1 China Molecular Influenza Diagnostic Market Forecast
10.3.2 Japan Molecular Influenza Diagnostic Market Forecast
10.3.3 Korea Molecular Influenza Diagnostic Market Forecast
10.3.4 Southeast Asia Molecular Influenza Diagnostic Market Forecast
10.3.5 India Molecular Influenza Diagnostic Market Forecast
10.3.6 Australia Molecular Influenza Diagnostic Market Forecast
10.4 Europe Molecular Influenza Diagnostic Forecast by Country (2021-2026)
10.4.1 Germany Molecular Influenza Diagnostic Market Forecast
10.4.2 France Molecular Influenza Diagnostic Market Forecast
10.4.3 UK Molecular Influenza Diagnostic Market Forecast
10.4.4 Italy Molecular Influenza Diagnostic Market Forecast
10.4.5 Russia Molecular Influenza Diagnostic Market Forecast
10.5 Middle East & Africa Molecular Influenza Diagnostic Forecast by Region (2021-2026)
10.5.1 Egypt Molecular Influenza Diagnostic Market Forecast
10.5.2 South Africa Molecular Influenza Diagnostic Market Forecast
10.5.3 Israel Molecular Influenza Diagnostic Market Forecast
10.5.4 Turkey Molecular Influenza Diagnostic Market Forecast
10.5.5 GCC Countries Molecular Influenza Diagnostic Market Forecast
10.6 Global Molecular Influenza Diagnostic Forecast by Type (2021-2026)
10.8 Global Molecular Influenza Diagnostic Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Molecular Influenza Diagnostic Product Offered
11.1.3 BD Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Information
11.2.2 Abbott (Include Alere) Molecular Influenza Diagnostic Product Offered
11.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Abbott (Include Alere) Main Business Overview
11.2.5 Abbott (Include Alere) Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Molecular Influenza Diagnostic Product Offered
11.3.3 Roche Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 SIEMENS
11.4.1 SIEMENS Company Information
11.4.2 SIEMENS Molecular Influenza Diagnostic Product Offered
11.4.3 SIEMENS Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 SIEMENS Main Business Overview
11.4.5 SIEMENS Latest Developments
11.5 Analytik Jena
11.5.1 Analytik Jena Company Information
11.5.2 Analytik Jena Molecular Influenza Diagnostic Product Offered
11.5.3 Analytik Jena Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Analytik Jena Main Business Overview
11.5.5 Analytik Jena Latest Developments
11.6 Quidel
11.6.1 Quidel Company Information
11.6.2 Quidel Molecular Influenza Diagnostic Product Offered
11.6.3 Quidel Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Quidel Main Business Overview
11.6.5 Quidel Latest Developments
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Information
11.7.2 Thermo Fisher Molecular Influenza Diagnostic Product Offered
11.7.3 Thermo Fisher Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Thermo Fisher Main Business Overview
11.7.5 Thermo Fisher Latest Developments
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Information
11.8.2 Meridian Bioscience Molecular Influenza Diagnostic Product Offered
11.8.3 Meridian Bioscience Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Meridian Bioscience Main Business Overview
11.8.5 Meridian Bioscience Latest Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Information
11.9.2 BioMerieux Molecular Influenza Diagnostic Product Offered
11.9.3 BioMerieux Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 BioMerieux Main Business Overview
11.9.5 BioMerieux Latest Developments
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Information
11.10.2 Sekisui Diagnostics Molecular Influenza Diagnostic Product Offered
11.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Sekisui Diagnostics Main Business Overview
11.10.5 Sekisui Diagnostics Latest Developments
11. Response Biomedical
11.11.1 Response Biomedical Company Information
11.11.2 Response Biomedical Molecular Influenza Diagnostic Product Offered
11.11.3 Response Biomedical Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Response Biomedical Main Business Overview
11.11.5 Response Biomedical Latest Developments
11.12 SA Scientific
11.12.1 SA Scientific Company Information
11.12.2 SA Scientific Molecular Influenza Diagnostic Product Offered
11.12.3 SA Scientific Molecular Influenza Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 SA Scientific Main Business Overview
11.12.5 SA Scientific Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Molecular Influenza Diagnostic Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Table 3. Major Players of Nucleic Acid Sequence Based Amplification (NASBA) Tests
Table 4. Major Players of Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Table 5. Major Players of Simple Amplification-based Assays (SAMBA)
Table 6. Molecular Influenza Diagnostic Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Molecular Influenza Diagnostic Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Molecular Influenza Diagnostic Market Size Market Share by Type (2016-2021)
Table 9. Molecular Influenza Diagnostic Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Molecular Influenza Diagnostic Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Molecular Influenza Diagnostic Market Size Market Share by Application (2016-2021)
Table 12. Global Molecular Influenza Diagnostic Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Molecular Influenza Diagnostic Revenue Market Share by Players (2019-2021E)
Table 14. Molecular Influenza Diagnostic Key Players Head office and Products Offered
Table 15. Molecular Influenza Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Molecular Influenza Diagnostic Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Molecular Influenza Diagnostic Market Size Market Share by Regions 2016-2021
Table 20. Americas Molecular Influenza Diagnostic Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Molecular Influenza Diagnostic Market Size Market Share by Country (2016-2021)
Table 22. Americas Molecular Influenza Diagnostic Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Molecular Influenza Diagnostic Market Size Market Share by Type (2016-2021)
Table 24. Americas Molecular Influenza Diagnostic Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Molecular Influenza Diagnostic Market Size Market Share by Application (2016-2021)
Table 26. APAC Molecular Influenza Diagnostic Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Molecular Influenza Diagnostic Market Size Market Share by Region (2016-2021)
Table 28. APAC Molecular Influenza Diagnostic Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Molecular Influenza Diagnostic Market Size Market Share by Type (2016-2021)
Table 30. APAC Molecular Influenza Diagnostic Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Molecular Influenza Diagnostic Market Size Market Share by Application (2016-2021)
Table 32. Europe Molecular Influenza Diagnostic Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Molecular Influenza Diagnostic Market Size Market Share by Country (2016-2021)
Table 34. Europe Molecular Influenza Diagnostic Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Molecular Influenza Diagnostic Market Size Market Share by Type (2016-2021)
Table 36. Europe Molecular Influenza Diagnostic Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Molecular Influenza Diagnostic Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Molecular Influenza Diagnostic Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Molecular Influenza Diagnostic
Table 45. Key Application and Potential Industries of Molecular Influenza Diagnostic
Table 46. Key Challenges of Molecular Influenza Diagnostic
Table 47. Key Trends of Molecular Influenza Diagnostic
Table 48. Global Molecular Influenza Diagnostic Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Molecular Influenza Diagnostic Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Molecular Influenza Diagnostic Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Molecular Influenza Diagnostic Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Molecular Influenza Diagnostic Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Molecular Influenza Diagnostic Market Size Market Share Forecast by Application (2021-2026)
Table 54. BD Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 55. BD Molecular Influenza Diagnostic Product Offered
Table 56. BD Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. BD Main Business
Table 58. BD Latest Developments
Table 59. Abbott (Include Alere) Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 60. Abbott (Include Alere) Molecular Influenza Diagnostic Product Offered
Table 61. Abbott (Include Alere) Main Business
Table 62. Abbott (Include Alere) Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. Abbott (Include Alere) Latest Developments
Table 64. Roche Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 65. Roche Molecular Influenza Diagnostic Product Offered
Table 66. Roche Main Business
Table 67. Roche Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. Roche Latest Developments
Table 69. SIEMENS Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 70. SIEMENS Molecular Influenza Diagnostic Product Offered
Table 71. SIEMENS Main Business
Table 72. SIEMENS Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. SIEMENS Latest Developments
Table 74. Analytik Jena Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 75. Analytik Jena Molecular Influenza Diagnostic Product Offered
Table 76. Analytik Jena Main Business
Table 77. Analytik Jena Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Analytik Jena Latest Developments
Table 79. Quidel Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 80. Quidel Molecular Influenza Diagnostic Product Offered
Table 81. Quidel Main Business
Table 82. Quidel Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. Quidel Latest Developments
Table 84. Thermo Fisher Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 85. Thermo Fisher Molecular Influenza Diagnostic Product Offered
Table 86. Thermo Fisher Main Business
Table 87. Thermo Fisher Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. Thermo Fisher Latest Developments
Table 89. Meridian Bioscience Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 90. Meridian Bioscience Molecular Influenza Diagnostic Product Offered
Table 91. Meridian Bioscience Main Business
Table 92. Meridian Bioscience Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. Meridian Bioscience Latest Developments
Table 94. BioMerieux Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 95. BioMerieux Molecular Influenza Diagnostic Product Offered
Table 96. BioMerieux Main Business
Table 97. BioMerieux Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. BioMerieux Latest Developments
Table 99. Sekisui Diagnostics Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 100. Sekisui Diagnostics Molecular Influenza Diagnostic Product Offered
Table 101. Sekisui Diagnostics Main Business
Table 102. Sekisui Diagnostics Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. Sekisui Diagnostics Latest Developments
Table 104. Response Biomedical Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 105. Response Biomedical Molecular Influenza Diagnostic Product Offered
Table 106. Response Biomedical Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. Response Biomedical Main Business
Table 108. Response Biomedical Latest Developments
Table 109. SA Scientific Details, Company Type, Molecular Influenza Diagnostic Area Served and Its Competitors
Table 110. SA Scientific Molecular Influenza Diagnostic Product Offered
Table 111. SA Scientific Main Business
Table 112. SA Scientific Molecular Influenza Diagnostic Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 113. SA Scientific Latest Developments
List of Figures
Figure 1. Molecular Influenza Diagnostic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Influenza Diagnostic Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Molecular Influenza Diagnostic Market Size Market Share by Type in 2020
Figure 7. Molecular Influenza Diagnostic in Hospitals
Figure 8. Global Molecular Influenza Diagnostic Market: Hospitals (2016-2021) & ($ Millions)
Figure 9. Molecular Influenza Diagnostic in POCT
Figure 10. Global Molecular Influenza Diagnostic Market: POCT (2016-2021) & ($ Millions)
Figure 11. Molecular Influenza Diagnostic in Others
Figure 12. Global Molecular Influenza Diagnostic Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Molecular Influenza Diagnostic Market Size Market Share by Application in 2020
Figure 14. Global Molecular Influenza Diagnostic Revenue Market Share by Player in 2020
Figure 15. Global Molecular Influenza Diagnostic Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Molecular Influenza Diagnostic Market Size 2016-2021 ($ Millions)
Figure 17. APAC Molecular Influenza Diagnostic Market Size 2016-2021 ($ Millions)
Figure 18. Europe Molecular Influenza Diagnostic Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Molecular Influenza Diagnostic Market Size 2016-2021 ($ Millions)
Figure 20. Americas Molecular Influenza Diagnostic Market Size Market Share by Country in 2020
Figure 21. Americas Molecular Influenza Diagnostic Market Size Market Share by Type in 2020
Figure 22. Americas Molecular Influenza Diagnostic Market Size Market Share by Application in 2020
Figure 23. United States Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Molecular Influenza Diagnostic Market Size Market Share by Regions in 2020
Figure 27. APAC Molecular Influenza Diagnostic Market Size Market Share by Type in 2020
Figure 28. APAC Molecular Influenza Diagnostic Market Size Market Share by Application in 2020
Figure 29. China Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Molecular Influenza Diagnostic Market Size Market Share by Country in 2020
Figure 36. Europe Molecular Influenza Diagnostic Market Size Market Share by Type in 2020
Figure 37. Europe Molecular Influenza Diagnostic Market Size Market Share by Application in 2020
Figure 38. Germany Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Molecular Influenza Diagnostic Market Size Market Share by Application in 2020
Figure 46. Egypt Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Molecular Influenza Diagnostic Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 52. APAC Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 53. Europe Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 55. United States Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 56. Canada Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 59. China Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 60. Japan Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 61. Korea Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 63. India Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 64. Australia Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 65. Germany Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 66. France Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 67. UK Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 68. Italy Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 69. Russia Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 70. Spain Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 73. Israel Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Molecular Influenza Diagnostic Market Size 2021-2026 ($ Millions)